$138.5
Insights on Balchem Corp
Revenue is down for the last 4 quarters, 232.54M → 228.69M (in $), with an average decrease of 0.6% per quarter
Netprofit is down for the last 3 quarters, 30.11M → 26.64M (in $), with an average decrease of 5.9% per quarter
In the last 1 year, Ecolab Inc. has given 35.2% return, outperforming this stock by 23.6%
0.4%
Downside
Day's Volatility :1.37%
Upside
0.97%
84.29%
Downside
52 Weeks Volatility :86.36%
Upside
13.18%
Period | Balchem Corp | Sector (Materials) | Index (Russel 2000) |
---|---|---|---|
3 Months | -0.67% | 7.8% | 0.0% |
6 Months | 13.82% | 18.7% | 0.0% |
1 Year | 11.61% | 13.3% | 2.2% |
3 Years | 11.5% | 6.7% | -23.0% |
Market Capitalization | 4.5B |
Book Value | $32.68 |
Dividend Share | 0.79 |
Dividend Yield | 0.56% |
Earnings Per Share (EPS) | 3.35 |
PE Ratio | 41.98 |
PEG Ratio | 4.46 |
Wall Street Target Price | 154.33 |
Profit Margin | 11.77% |
Operating Margin TTM | 15.75% |
Return On Assets TTM | 6.09% |
Return On Equity TTM | 10.9% |
Revenue TTM | 922.4M |
Revenue Per Share TTM | 28.73 |
Quarterly Revenue Growth YOY | -1.6% |
Gross Profit TTM | 280.5M |
EBITDA | 211.5M |
Diluted Eps TTM | 3.35 |
Quarterly Earnings Growth YOY | 0.24 |
EPS Estimate Current Year | 4.27 |
EPS Estimate Next Year | 4.79 |
EPS Estimate Current Quarter | 0.93 |
EPS Estimate Next Quarter | 0.95 |
What analysts predicted
Upside of 11.43%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 643.7M | ↑ 8.22% |
Net Income | 78.6M | ↓ 12.77% |
Net Profit Margin | 12.21% | ↓ 2.93% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 643.7M | ↑ 0.0% |
Net Income | 79.7M | ↑ 1.4% |
Net Profit Margin | 12.38% | ↑ 0.17% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 703.6M | ↑ 9.31% |
Net Income | 84.6M | ↑ 6.22% |
Net Profit Margin | 12.03% | ↓ 0.35% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 799.0M | ↑ 13.56% |
Net Income | 96.1M | ↑ 13.57% |
Net Profit Margin | 12.03% | ↑ 0.0% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 942.4M | ↑ 17.94% |
Net Income | 105.4M | ↑ 9.64% |
Net Profit Margin | 11.18% | ↓ 0.85% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 922.4M | ↓ 2.11% |
Net Income | 108.5M | ↑ 3.01% |
Net Profit Margin | 11.77% | ↑ 0.59% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 244.3M | ↑ 3.2% |
Net Income | 25.2M | ↓ 15.22% |
Net Profit Margin | 10.34% | ↓ 2.24% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 232.5M | ↓ 4.8% |
Net Income | 21.4M | ↓ 15.22% |
Net Profit Margin | 9.21% | ↓ 1.13% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 232.5M | ↑ 0.0% |
Net Income | 22.7M | ↑ 6.09% |
Net Profit Margin | 9.77% | ↑ 0.56% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 231.3M | ↓ 0.55% |
Net Income | 30.1M | ↑ 32.58% |
Net Profit Margin | 13.02% | ↑ 3.25% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 229.9M | ↓ 0.56% |
Net Income | 29.1M | ↓ 3.44% |
Net Profit Margin | 12.64% | ↓ 0.38% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 228.7M | ↓ 0.54% |
Net Income | 26.6M | ↓ 8.35% |
Net Profit Margin | 11.65% | ↓ 0.99% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 981.4M | ↑ 1.84% |
Total Liabilities | 289.7M | ↓ 16.44% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 1.2B | ↑ 17.76% |
Total Liabilities | 412.0M | ↑ 42.2% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.2B | ↑ 0.88% |
Total Liabilities | 337.6M | ↓ 18.06% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 1.2B | ↑ 2.87% |
Total Liabilities | 322.3M | ↓ 4.53% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 1.6B | ↑ 35.45% |
Total Liabilities | 686.2M | ↑ 112.91% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 1.6B | ↑ 0.04% |
Total Liabilities | 571.2M | ↓ 16.77% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↑ 1.64% |
Total Liabilities | 737.1M | ↑ 4.51% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↓ 0.52% |
Total Liabilities | 686.2M | ↓ 6.9% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↑ 0.26% |
Total Liabilities | 655.3M | ↓ 4.5% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↓ 0.59% |
Total Liabilities | 612.3M | ↓ 6.56% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↓ 0.97% |
Total Liabilities | 578.2M | ↓ 5.57% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↑ 1.35% |
Total Liabilities | 571.2M | ↓ 1.22% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 118.7M | ↑ 7.3% |
Investing Cash Flow | -32.0M | ↓ 25.07% |
Financing Cash Flow | -71.4M | ↑ 4.11% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 124.5M | ↑ 4.86% |
Investing Cash Flow | -156.2M | ↑ 388.34% |
Financing Cash Flow | 43.4M | ↓ 160.72% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 150.5M | ↑ 20.92% |
Investing Cash Flow | -34.6M | ↓ 77.86% |
Financing Cash Flow | -101.2M | ↓ 333.18% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 160.5M | ↑ 6.66% |
Investing Cash Flow | -35.3M | ↑ 2.05% |
Financing Cash Flow | -102.2M | ↑ 1.0% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 138.5M | ↓ 13.69% |
Investing Cash Flow | -416.0M | ↑ 1078.51% |
Financing Cash Flow | 246.7M | ↓ 341.42% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 41.6M | ↓ 13.72% |
Investing Cash Flow | -85.1M | ↓ 72.22% |
Financing Cash Flow | 28.4M | ↓ 89.66% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 41.7M | ↑ 0.08% |
Investing Cash Flow | -14.5M | ↓ 82.98% |
Financing Cash Flow | -21.4M | ↓ 175.39% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 34.8M | ↓ 16.37% |
Investing Cash Flow | -10.1M | ↓ 30.56% |
Financing Cash Flow | -33.3M | ↑ 55.68% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 35.0M | ↑ 0.44% |
Investing Cash Flow | -3.6M | ↓ 64.11% |
Financing Cash Flow | -24.8M | ↓ 25.69% |
Sell
Neutral
Buy
Balchem Corp is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Balchem Corp | -9.74% | 13.82% | 11.61% | 11.5% | 38.46% |
Air Products & Chemicals Inc. | -1.16% | -15.34% | -17.71% | -18.99% | 16.05% |
Lyondellbasell Industries N.v. | -1.44% | 10.93% | 10.02% | -5.01% | 13.26% |
Linde Plc | -5.07% | 19.85% | 21.6% | 53.3% | 148.98% |
Sherwin-williams Company, The | -10.87% | 28.23% | 33.16% | 13.09% | 100.24% |
Ecolab Inc. | -3.7% | 38.74% | 35.19% | -3.1% | 18.88% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Balchem Corp | 41.98 | 41.98 | 4.46 | 4.27 | 0.11 | 0.06 | 0.01 | 32.68 |
Air Products & Chemicals Inc. | 22.41 | 22.41 | 1.37 | 12.32 | 0.15 | 0.05 | 0.03 | 66.91 |
Lyondellbasell Industries N.v. | 15.55 | 15.55 | 1.8 | 8.26 | 0.16 | 0.06 | 0.05 | 39.85 |
Linde Plc | 35.35 | 35.35 | 2.65 | 14.48 | 0.15 | 0.06 | 0.01 | 82.33 |
Sherwin-williams Company, The | 32.35 | 32.35 | 4.16 | 11.43 | 0.72 | 0.1 | 0.01 | 13.88 |
Ecolab Inc. | 46.09 | 46.09 | 2.33 | 6.39 | 0.18 | 0.06 | 0.01 | 23.46 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Balchem Corp | Buy | $4.5B | 38.46% | 41.98 | 11.77% |
Air Products & Chemicals Inc. | Buy | $52.2B | 16.05% | 22.41 | 18.82% |
Lyondellbasell Industries N.v. | Hold | $32.8B | 13.26% | 15.55 | 5.14% |
Linde Plc | Buy | $214.0B | 148.98% | 35.35 | 18.87% |
Sherwin-williams Company, The | Buy | $77.2B | 100.24% | 32.35 | 10.52% |
Ecolab Inc. | Hold | $63.1B | 18.88% | 46.09 | 8.96% |
BlackRock Inc
Vanguard Group Inc
Apg All Pensions Group
Wasatch Advisors LP
State Street Corporation
Conestoga Capital Advisors, LLC
founded in 1967, balchem provides state-of-the-art solutions and the finest quality products for a range of industries worldwide. our company consists of four business segments: human nutrition & health; specialty products; animal nutrition and health and industrial products. balchem employs approximately 1,000 people worldwide who are engaged in many diverse activities, developing our company into chosen market leadership positions. visit our website at www.balchem.com to learn more about us and the exciting opportunities we have available!
Organization | Balchem Corp |
Employees | 1302 |
CEO | Mr. Theodore L. Harris |
Industry | Process Industries |
Cerevel Therapeutics Holdings Inc
$138.50
-1.52%
Vaxcyte Inc
$138.50
-1.52%
Janux Therapeutics Inc
$138.50
-1.52%
Spdr Nuveen S&p High Yield Municipal Bond Etf
$138.50
-1.52%
Radnet Inc
$138.50
-1.52%
The St. Joe Co
$138.50
-1.52%
Harley-davidson, Inc.
$138.50
-1.52%
Vaneck Vectors Fallen Angel Hiyld Bd Etf
$138.50
-1.52%
Aurora Innovation Inc
$138.50
-1.52%